REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Alianza-Adn Farma S.A.S. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Alianza-Adn Farma S.A.S. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Alianza-Adn Farma S.A.S. is a company in Ecuador, with a head office in Quito. The enterprise operates in the Medical and Diagnostic Laboratories industry. It was established on May 26, 2021. 3 (2024) employees currently work for Alianza-Adn Farma S.A.S.. The latest financial highlights indicate a net sales revenue increase of 23.63% in 2025. Its total assets decreased by 9.2% over the same period. The net profit margin of Alianza-Adn Farma S.A.S. increased by 0.11% in 2025.

Headquarters
Av. America, Oe2
Quito; Pichincha;

Contact Details: Purchase the Alianza-Adn Farma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Alianza-Adn Farma S.A.S. report to view the information.
Registered Capital:
Purchase the Alianza-Adn Farma S.A.S. report to view the information.
Financial Auditors:
Purchase the Alianza-Adn Farma S.A.S. report to view the information.
Incorporation Date:
May 26, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
79%
Purchase this report to view the information.
21%
Company Performance
Financial values in the chart are available after Alianza-Adn Farma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
23.63%▲
Total Operating Revenue
23.63%▲
Operating Profit
108.1%▲
EBITDA
42.29%▲
Net Profit/Loss for the Period
115.4%▲
Total Assets
-9.2%▼
Total Equity
7.61%▲
Operating Profit Margin
0.56%▲
Net Profit Margin
0.11%▲
Return on Equity (ROE)
3.54%▲
Quick Ratio
0.03%▲
Cash Ratio
-0.18%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo